Breast Cancer Drug Found to be Ineffective in Treating Squamous Non-Small Cell Lung Cancer
PHILADELPHIA (June 2, 2017) - Martin J. Edelman, MD, FACP, chair of Hematology/Oncology at Fox Chase Cancer Center, presented the results of a clinical study testing palbociclib at the American Society of Clinical Oncology annual meeting in Chicago. Of the 32 patients evaluated, only two responded to the drug, showing it to be ineffective on its own for patients with squamous NSCLC.